Molecular Modeling-Based Delivery System Enhances Everolimus-Induced Apoptosis in Caco-2 Cells
Several studies have shown that the mammalian target of rapamycin (mTOR) inhibitor; everolimus (EV) improves patient survival in several types of cancer. However, the meaningful efficacy of EV as a single agent for the treatment of colorectal cancer (CRC) has failed to be proven in multiple clinical...
| 出版年: | ACS Omega |
|---|---|
| 第一著者: | |
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
American Chemical Society
2019
|
| オンライン･アクセス: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066960433&doi=10.1021%2facsomega.9b00109&partnerID=40&md5=4bcb43e34dd07537585b3109737c377c |